Skip to main content

Bivalent OPV Type 1 and 3 Poliomyelitis Vaccine, Live (Oral)

Product overview

Type
Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3
Commercial Name
Bivalent OPV Type 1 and 3 Poliomyelitis Vaccine, Live (Oral)
Manufacturer
Panacea Biotec Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
20
Diluent
Not Applicable
Route of Administration
Oral
Shelf Life
24 months
Storage Temperature
-20°C
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton of 50 vials (1000 doses) [Dimensions: 4.7 x 9.1 x 17.8 cm]
Tertiary Packaging
Shipping box containing 16 cartons of 50 vials (800 vials/ 16000 doses) [Dimensions: 40 x 43.9 x 56.9 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
none
Cold Chain Volume
0.76 cm3/dose (in secondary packaging)

Attachments

Container Photo
Container Photo
Package Insert